Introduction
We published the results of a French national survey, 'Parcours de Femme 1993', of 2874 patients presenting with female cancer [1] . The study, the first of its kind in France, showed that patient information on disease, prognosis, treatment and side-effects was markedly inadequate and failed to meet patients' requirements. In 1997, a comparable study conducted in 13 136 European patients led to similar conclusions with respect to information inadequacy [2] .
In 2001, we conducted this cross-sectional, observational study, the objective of which was to define the management of patients treated for female cancer at various stages of care.
Four data categories were identified: information relating to diagnosis, disease and treatments; physical, psychological, material, familial and professional problems encountered, and the assistance and support given; relations with medical personnel and other caregivers; and organization of the medical, paramedical and social procedures involved.
Patients and methods
Inclusion criteria were women with gynecological (ovarian, uterus) or breast cancer, irrespective of age or disease stage at diagnosis. Treatment was to have been initiated at least 3 months previously or completed <1 year before inclusion.
A steering committee (comprising four clinicians and a nurse: J.M.D., J.G., N.G., P.R. and D.S.) was formed to develop the methodology. Interviews with physicians, caregivers and patients provided source material for the questionnaires. A scientific committee (independent experts) was set up to validate the scientific quality of the project, the objectives and the methodology. The 'patient' questionnaire was constructed specifically for the survey using data generated by interviews with 30 patients. 'Physician' and 'caregiver' questionnaires were tested in 15 centers. A need to compile two types of 'patient' questionnaires was identified: one for group A, in which the disease was at an initial stage, and one for group B, in which the patients had recurrent disease. The contents of the questionnaires are summarized in Table 1 .
All eligible patients were given a mini-dossier explaining the study aims, and were asked to complete the questionnaire themselves and return it in a pre-paid envelope. The physician who was responsible for the patient completed a specific questionnaire and gave the nurse or radiotherapist a specific 'caregiver' questionnaire. The selection of physicians was based on geographical criteria. This study met the standard quality requirements of the humanities and social sciences. Patient anonymity was respected and participation in the study was voluntary. Patient recruitment, however, may have been biased due to differences in the motivation of the medical teams, and the choice of patients and volunteers.
Given the response rate (RR) observed in the previous survey (28%) [1] , the number of patient questionnaires to be distributed was estimated to be 3000 in order to obtain 1000 completed contributor responses. The number of centers was set at 100, based on a mean recruitment figure of 30 patients per center. The COSI software package, version 3.5 (STATIRO w , Montrouge, France), was used for statistical analysis. The x 2 -test was used to compare qualitative data (populations, percentages) and Student's t-test was used for quantitative data (mean, standard deviation). An analysis comparing the matched questionnaires (patientphysician, patient-caregiver, physician-caregiver-patient) was performed to demonstrate concordance/discordance between the groups.
Results
From February to November 2001, 2839 patients were enrolled by 104 physicians from 85 centers ( Figure 1 ) and 1870 questionnaires were returned (RR 66%; Figure 2 ). The number of physician questionnaires analyzed was 2547 (90% RR), while that for caregivers was 1760 (62% RR). The physicianpatient (n = 572) and physician -caregiver -patient (n = 1073) match rate was 67%. The physician -caregiver -patient and patient -caregiver (n = 69) match rate was 65%. The number of matched physician -caregiver questionnaires was 552.
Patient characteristics
The majority of patients had breast cancer (87%); 76% of the women were newly diagnosed (group A, n = 1419) and 24% had recurrent disease (group B, n = 451) ( Table 2 ; Figure 3 ). The only significant differences observed between groups concerned working activity.
Diagnosis announcement
While 92% of women reported having received explanations with regard to diagnosis (94% group A, 84% group B), only 43% of them were fully satisfied and 35% were fairly satisfied ( Figure 4 ). Inadequate information was reported by 22% of patients (19% group A, 34% group B). The majority of patients (81%) reported that they had had the opportunity of putting any questions they wished to the medical team. Overall, 29% of patients considered that they had not been told everything about the foreseeable course of their disease and the problems that the disease was likely to induce. This was more marked in group B: 44% of patients lacked information on the course of disease and 39% on problems engendered by the disease.
Information and choice of treatment
Almost all patients received information on the type (95%), objective (90%), implementation and practical conditions (90%) of treatment. Shortcomings were nonetheless reported with respect to information on treatment, namely drug names (27%), side-effects and severity (25%), and therapeutic resources for the alleviation of adverse reactions (20%). Inadequate information on these items was experienced more frequently by relapsed patients who specifically specified the need for more information on the total duration of treatment (29% of patients with recurrent disease needed more information on the total duration of treatment compared with 8% of patients with de novo disease). With respect to therapeutic options, physicians gave detailed explanations to 18% of patients (16% group A, 21% group B) and in 63% of cases, patients recognized that they had a choice between the options. However, the treatment was prescribed without any explanation for 48% of patients, and the prescribed treatment was presented as the only option for 25% of patients. Of the 207 patients who participated in therapeutic decision discussions, 87% were given time to think over the propositions and 31% were given the opportunity to obtain another opinion. While only 15% of patients were given the opportunity to be included in a clinical trial, 79% of them accepted (77% group A, 87% group B). The main reasons for acceptance were the opportunity to contribute to medical progress (59%) and/or to benefit from the most recent advances in research (53%).
Complementary information
The need for complementary information on the disease or treatments or a second opinion appeared to depend on initial diagnosis, patient age and inadequacy of information at the time of management initiation. Sixty per cent of the women (mainly young and newly diagnosed) sought complementary information on their disease or treatment. Women experiencing recurrence were more passive in this context, independent of their age. Figure 5 details the sources of information. Thirtythree per cent of patients sought a second opinion, of whom 42% had the impression that they were not given all the necessary information at the start of disease management. The 624 patients who consulted another physician most frequently did so upon their own initiative (73%). The main objectives were to obtain further information on the disease (53% of patients who consulted another physician) and to investigate treatment alternatives (50% of patients experiencing recurrence). Group A patients turned more frequently to a general practitioner (GP) (62%), while those in group B consulted another oncologist (61%). An information brochure was given more frequently to group A patients (56%, compared with 27% of group B patients) and to breast cancer patients (50%, compared with 33 -39% for gynecological cancers). The brochure, compiled in the majority of cases by the health care center (68%), covered the disease and its treatment (26% of cases), or only the disease (7%) or drugs (16%). The fact that patients received a brochure did not prevent them from seeking further information.
Difficulties encountered during treatment (Table 3) and disease management (Table 4) Pain. Pain was frequent from the time of disease onset (45% of patients) and was independent of disease stage or tumor site. For 70% of group A patients, pain was experienced at the time of surgery, while 65% of group B patients experienced pain at the time of relapse, before treatment initiation. Pain was experienced during the treatment period (chemotherapy and radiotherapy) in 70% of patients, irrespective of disease stage. Irrespective of the time of pain onset, 25% of patients regretted the absence of pain management. Where pain was managed, treatment efficacy was rated as positive in over two-thirds of patients, particularly with regard to pain experienced in the perioperative period (88% positive). Onethird of the 840 patients reporting pain were receiving analgesic treatment (24% group A, 56% group B). In the majority of cases, the oncologist initiated treatment (55%) and the attending physician renewed the prescription (53%).
Physical problems. The most frequent physical problems were fatigue (78%), alopecia (63%) and gastrointestinal disorders (61%). The physician -patient concordant response rates were 65% for fatigue, 63% for alopecia and 48% for nausea/vomiting. Management of the latter was excellent in 64% of cases. In contrast, fatigue appeared to be inadequately managed, with 27% of patients reporting that they had been offered support while 36% reported receiving none.
Psychological problems. The most frequent psychological problems were anxiety (66%), sleep disorders (48%) and depression (37%). Anxiety was almost always detected by physicians and caregivers (2% and 7% of 'don't know' responses, respectively). However, support was only offered in 44% of cases. Sleep disorders were managed in 40% of patients, but the problem was poorly recognized by physicians and caregivers (12% and 33% of 'don't know' responses, respectively).
Problems in daily and social life. Almost half of women reported difficulty in doing housework (48%), but in 40% of cases no assistance was proposed. Similarly, almost one woman in two complained of the non-management of problems concerning affective and sexual relations with their partner (50%), child care (49%), relations with health insurance organizations (50%), financial difficulties (45%), professional life (42%) and relations with family and friends (41%). These problems were difficult to manage in that they were mostly unidentified by caregivers ('don't know' responses: 10 to 39% for physicians and 36 to 62% for caregivers, depending on the problem encountered). For instance, housework problems were poorly recognized by caregivers, while physicians perceived them more clearly (patient concordance rate: 30% for caregivers and 44% for physicians). The differences in concordance between nurses and radiotherapists, on the one hand, and physicians, on the other, were particularly marked with respect to administrative, material and affective problems. Even when problems were noted, little support was offered.
Problems with care organization. Care and administrative formalities inherent to cancer were more effectively managed by caregivers. Group B patients responded that three areas required improvement: waiting before chemotherapy sessions (35% in group B versus 25% in group A), difficulty getting in touch with the physician quickly (15% versus 11%) and difficulties in confidential access to the physician (13% versus 9%).
Home management. In 80% of patients, home follow-up was conducted by a GP. The GP was in close contact with the refering caregiver (88% of cases) and was closely involved in disease management (85%), particularly with regard to the organization of patient follow-up. In the follow-up of relapsed patients, the GP was most closely involved in the treatment of symptoms such as fatigue, gastrointestinal disorders and pain. The GP also played an important supportive role for 84% of patients with relapsed disease.
Discussion
The number of patients included in this study was high compared with other similar published surveys [3] [4] [5] [6] . The questionnaire RR of 66% is one of the best rates observed in similar studies and shows a marked improvement on 'Parcours de Femmes 1993' (28%) and (Caring About Women and Cancer) (43%) [1, 2, 6, 7] . This could be explained in part by the method of distribution of questionnaires, which were given directly to patients by doctors or nurses, and to heightened patient awareness after an effective information campaign (small posters in consulting rooms, etc.).
Patients appeared to be better informed in 2001 than in 1993. While almost all patients reported that they were informed about their disease at the time of initial diagnosis, information was inadequate in the event of recurrent disease, in particular with respect to the foreseeable course of the disease, prognosis and the probability of recovery. The desire for more exhaustive information was reported in other studies, irrespective of disease stage [4, 8] . During initial treatment, Lobb's study showed that 91% of patients wished to be informed about their prognosis and 63% felt that their oncologist should specifically ask them whether they wished to be informed about their prognosis [9] . Women also felt that the clinician should check they had correctly understood the information given, give them the opportunity to ask questions (99%) and explain fully the medical terms used (98%). Providing the patient with information on their disease is essential since it has been shown to reduce anxiety and depression [10] . The converse is also true [11] . Alliot stressed the inadequacy of information on drug names [12] . All types of diseases confounded, only 45% of French patients are correctly aware of their treatment, while 20% are totally ignorant about it; 51% of the patients in Tamburini's study [13] and 82% in Stiggelbout's study [14] felt the need to be better informed. The provision of written information does not necessarily ensure greater comprehension; patients prefer to obtain information directly from medical personnel [15, 16] . The present survey also demonstrated the authoritarian manner of medical decision making: only 18% of patients were proposed alternative treatments by their physician. Bruera et al. showed that 89% of breast cancer patients preferred to play an active role in treatment decision making [17] . The patient's point of view was only taken into account by 42% of attending physicians. A recent study showed that in patients with incurable cancers, decision-making regarding palliative treatment was anxiogenic [18] . Anxiety was not related to information delivery, but rather to the degree of active participation demanded by the physician. Patients in a precarious general condition and elderly patients preferred treatment decisions to be made by the physician.
In this study, 60% of patients sought complementary information. Patients and former patients are an important information source (64%): contact with a woman who has successfully coped with disease may be very helpful to newly diagnosed patients. People working in a medical environment constitute a source of information in 55% of cases. The main sources of information were the media (for 65% of patients), i.e. the lay press, television, newspapers, magazines. The Internet was used by 13% of patients in their search for additional information on their disease and treatments.
Pain at the time of diagnostic procedures was inadequately managed. Only the perioperative period was managed correctly: analgesic treatment was considered fully effective by 32% of patients and moderately effective by 55% at the time of surgery. The French perception of analgesic treatment was investigated by Larue in 1990 and 1996 [19] . Oncological pain was better understood in 1996: 65% of respondents considered that while pain was rare in the early stages of disease (compared with 49% in 1990), it was frequent in the more advanced stages (84% in 1996 compared with 72% in 1990). More than half of the subjects reported that their information on pain treatment was derived from television (59%), the press (47%) and caregivers (45%). Given that the overall population is increasingly well informed about pain and its treatment, we must now determine why pain remains such a problem at certain stages of the disease.
Fatigue was the physical problem most frequently reported by patients in the present study (78%). Fatigue may be secondary to physical factors such as anemia, pain, inactivity, inadequate diet, vomiting, infection or fever, but may also be related to psychological causes such as anxiety, depression, insomnia and anticipatory nausea [20, 21] . A study of 544 patients treated with chemotherapy or radiotherapy reported regular fatigue in 78% of cases, and daily or almost daily fatigue in 53% of cases. The family considered that the patient was tired in 86% of cases and physicians reported it in 75% of cases. Fatigue has a marked impact on the patient's everyday quality of life, notably work (61%), physical well-being (60%) and psychological well-being (51%). However, fatigue is rarely spontaneously reported to the physician during consultation (two-thirds of patients). It is important to encourage patients to express all components of their fatigue. 'Parcours de Femmes 2001' points to the difficulties of evaluating fatigue and managing fatigue, since there is no effective treatment for it, except symptomatic treatments intended to correct the underlying conditions. This survey also showed sleep disorders to be poorly identified by caregivers, probably due to lack of oriented questions. The relationship between fatigue and sleep disorders has been well documented, as have difficulties in measuring and treating fatigue. Fatigue is probably a key issue in the management of cancer care, but one which the professionals are ill equipped to deal with.
It has to be noted that the high percentages of patients suffering from fatigue or psychological problems such as anxiety, sleep disorders and depression can be related to the tumors concerned. Engel et al. showed that breast cancer patients, despite better prognoses, appear to suffer more psychological problems than rectal cancer patients [22] . In particular, they suffered significantly worse emotional functioning, fatigue, pain and sleeplessness. Female rectal cancer patients did not suffer the same problems [22] . This study was also designed to identify problems in daily and social life; 48% of patients suffered from problems in these domains and it is clear that caregivers and physicians tend to underestimate their importance (no support given in 40% of cases). In France, the social difficulties experienced by cancer patients are real and remain poorly managed. Dilhuydy et al. conducted a study in 200 patients, of whom 65% were referred to a social worker and 35% consulted one spontaneously [23] . The need for medical, social or associational follow-up was evidenced in 70% of cases. Administrative and psychosocial problems were the most frequent and were considered more important by the social worker than the patient. The problem is greater in patients with metastatic disease. The authors concluded that social worker consultation should be systematic and conducted early in the disease trajectory in order to implement preventive actions and appropriate follow up.
Perspectives
The high RR to the questionnaires demonstrates the interest of female cancer patients in the issues raised by this survey. Patients expect improvements in three major areas: information, physical/psychological disorders and material/ social problems. It is important to respond promptly to their demands by providing adequate solutions. Despite the satisfaction expressed in this survey, there is still room for improvement in certain areas: (i) better information about the side-effects of treatment and their intensity should help women to anticipate and control them better; (ii) information should not be restricted to diagnosis-prognosis should also be addressed; and (iii) more information should be provided to women with recurrent cancer. Information regarding prognosis or recurrence obviously requires tactful handling, as it may relieve or increase patient anxiety. Clearly, however, neither brochures nor the Internet are a substitute for a high quality physician -patient relationship.
Better understanding by physicians and other caregivers of patient's physical and psychological disorders has resulted in improved care in this area. Recent French government incentives have considerably raised awareness of pain and its treatment. Similarly, cancer patients are now being provided with more psychological support. French oncologists are being trained in psycho-oncology and are gaining an understanding of the patient experience. This in turn improves patientphysician interaction. Fatigue remains a key problem. The following measures should be considered. . Systematic assessment of fatigue, and more in-depth research into its causes and ways to remedy it. In cases for which there is no obvious treatment, supportive care measures that might facilitate the patient's daily life should be implemented.
. Greater attention should be given to sleep disorders and their identification by means of targeted examinations.
. Prevention and treatment of pain should be extended to the periods before and after treatments, and should include invasive diagnostic procedures.
Health-care teams' ignorance of the material and social problems of female cancer patients was highlighted in this survey. Who should take care of the domestic, financial, emotional and sexual problems that arise in a family struck by cancer when the woman's salary is needed to pay back debts? These issues are not traditionally managed by physicians. Does comprehensive care mean that this should no longer be the case? Admittedly, oncologists cannot become social workers or psychologists, but they must be able to identify psychosocial risk factors during consultation. They should have a proactive attitude in this area and do the following.
. Systematically assess patients' domestic problems, attempt to identify any financial, administrative or social difficulties, and where necessary orientate them to organizations that will help them cope with these issues. . Address patients' emotional problems in order to, at the very least, assess the impact treatment-related or other decisions have in this area.
In conclusion, 'Parcours de Femmes 2001' draws attention to the close relationship between the systemic nature of purely medical issues and the social, material and psychological problems of cancer patients. We, practitioners who treat these pathologies must work to help resolve them. We have outlined above a few relevant courses of action. Beyond this, only truly comprehensive patient management can be effective. At present, the different types of support available are scattered around various departments, and patients and physicians are either unaware of their existence or have difficulties accessing them. The same holds for patients' rights and their right to claim public assistance. Coordination of support within easyto-identify organizations in each cancer center would appear to be paramount [24] .
In France, the priorities included in the 'Plan Cancer' announced by the President of Republic on 24 March 2003 are the provision of psycho-oncological support to patients, the coordination of support services, and the need to use tact when making announcements to patients. Specifically, the cancer policy commission (Commission d'Orientation sur le Cancer) in France proposes that Functional Cancer Support Units [USO (Unités Fonctionnelles de Soins de Support en Oncologie)] that provide specific cancer-related care and bring together all those involved (i.e. psycho-oncologists, social workers, estheticians, etc.) be created [25] . The commission also calls for the standardization of consultations in which a cancer diagnosis is announced.
The 'Parcours de Femmes 2001' survey has drawn attention to both the progress made in terms of information provided to cancer patients in France and shortcomings regarding support services. New efforts made by health care teams and the new governmental measures currently under consideration, if they actually yield results, should result in progress in comprehensive patient management.
